Skip to content

Efficacy of capsule endoscopy in cirrhotic patients for the diagnosis of upper gastrointestinal lesions and small bowel abnormalities

Efficacy of capsule endoscopy in cirrhotic patients for the diagnosis of upper gastrointestinal lesions and small bowel abnormalities - Capsule endoscopy and gastrointestinal lesions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000028433
Enrollment
50
Registered
2017-07-28
Start date
2017-07-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal varices requiring endoscopic therapies

Interventions

Capsule endoscopy for patiens with esophageal varices receiving endoscopic therapy

Sponsors

Hyogo college of medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with portal hypertension who were determined to be necessary for prophylactic endoscopic therapies for esophageal varices

Exclusion criteria

Exclusion criteria: (1)Patients aged less than 18 years (2)Patients with gastrointestinal obstruction or fistula or those being suspected of having gastrointestinal obstruction or fistula (3)Patients with gastrointestinal stenosis in whom capsule endoscopy will be remained in the same place. (4)Patients with cardiac pacemakers or other implanted medical devices (5)Patients with dysphagia (6)Patients in whom consents for removal of remained CE are unable to be obtained (7)Patients who are unable to receive open surgery (8)Patients who were judged to be inappropriate for the study subjects

Design outcomes

Primary

MeasureTime frame
Prevalence for small bowel lesions (small bowel lesions will be defined as follows: (a) vascular lesion or (b) ulcerative lesion). Tumor lesion will not be included for small bowel lesions in this study.

Countries

Japan

Contacts

Public ContactYoshinori Iwata

Hyogo college of medicine Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine

yo-iwata@hyo-med.ac.jp0798-45-6472

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026